These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27035234)

  • 21. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
    Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
    Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamin 2-related centronuclear myopathy: clinical, histological and genetic aspects of further patients and review of the literature.
    Jeub M; Bitoun M; Guicheney P; Kappes-Horn K; Strach K; Druschky KF; Weis J; Fischer D
    Clin Neuropathol; 2008; 27(6):430-8. PubMed ID: 19130742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare case of centronuclear myopathy with
    Aghbolaghi AG; Lechpammer M
    Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
    Böhm J; Biancalana V; Dechene ET; Bitoun M; Pierson CR; Schaefer E; Karasoy H; Dempsey MA; Klein F; Dondaine N; Kretz C; Haumesser N; Poirson C; Toussaint A; Greenleaf RS; Barger MA; Mahoney LJ; Kang PB; Zanoteli E; Vissing J; Witting N; Echaniz-Laguna A; Wallgren-Pettersson C; Dowling J; Merlini L; Oldfors A; Bomme Ousager L; Melki J; Krause A; Jern C; Oliveira AS; Petit F; Jacquette A; Chaussenot A; Mowat D; Leheup B; Cristofano M; Poza Aldea JJ; Michel F; Furby A; Llona JE; Van Coster R; Bertini E; Urtizberea JA; Drouin-Garraud V; Béroud C; Prudhon B; Bedford M; Mathews K; Erby LA; Smith SA; Roggenbuck J; Crowe CA; Brennan Spitale A; Johal SC; Amato AA; Demmer LA; Jonas J; Darras BT; Bird TD; Laurino M; Welt SI; Trotter C; Guicheney P; Das S; Mandel JL; Beggs AH; Laporte J
    Hum Mutat; 2012 Jun; 33(6):949-59. PubMed ID: 22396310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
    Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
    Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells.
    González-Jamett AM; Baez-Matus X; Olivares MJ; Hinostroza F; Guerra-Fernández MJ; Vasquez-Navarrete J; Bui MT; Guicheney P; Romero NB; Bevilacqua JA; Bitoun M; Caviedes P; Cárdenas AM
    Sci Rep; 2017 Jul; 7(1):4580. PubMed ID: 28676641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing dynamin 2 (DNM2) rescues
    Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
    Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
    Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
    Tinelli E; Pereira JA; Suter U
    Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The dynamin-2-gene related centronuclear myopathy].
    Bitoun M
    Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy.
    Fujise K; Okubo M; Abe T; Yamada H; Takei K; Nishino I; Takeda T; Noguchi S
    Hum Mutat; 2022 Feb; 43(2):169-179. PubMed ID: 34837441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
    Böhm J; Barthélémy I; Landwerlin C; Blanchard-Gutton N; Relaix F; Blot S; Laporte J; Tiret L
    Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35244154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
    Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
    Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired excitation-contraction coupling in muscle fibres from the dynamin2
    Kutchukian C; Szentesi P; Allard B; Trochet D; Beuvin M; Berthier C; Tourneur Y; Guicheney P; Csernoch L; Bitoun M; Jacquemond V
    J Physiol; 2017 Dec; 595(24):7369-7382. PubMed ID: 29071728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Dominant Mutation in BIN1 Gene Causing Mild Centronuclear Myopathy Revealed by Myalgias and CK Elevation.
    Garibaldi M; Böhm J; Fattori F; Koch C; Surace C; Ottaviani P; Laschena F; Laporte J; Bertini E; Antonini G; Romero NB
    J Neuromuscul Dis; 2016 Mar; 3(1):111-114. PubMed ID: 27854204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort.
    Catteruccia M; Fattori F; Codemo V; Ruggiero L; Maggi L; Tasca G; Fiorillo C; Pane M; Berardinelli A; Verardo M; Bragato C; Mora M; Morandi L; Bruno C; Santoro L; Pegoraro E; Mercuri E; Bertini E; D'Amico A
    Neuromuscul Disord; 2013 Mar; 23(3):229-38. PubMed ID: 23394783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autosomal dominant centronuclear myopathy with unique clinical presentations.
    Lee JY; Min JH; Hong YH; Sung JJ; Park SH; Park SH; Lee KW; Park KS
    J Korean Med Sci; 2007 Dec; 22(6):1098-101. PubMed ID: 18162732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy.
    Biancalana V; Romero NB; Thuestad IJ; Ignatius J; Kataja J; Gardberg M; Héron D; Malfatti E; Oldfors A; Laporte J
    Acta Neuropathol Commun; 2018 Sep; 6(1):93. PubMed ID: 30208955
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.
    Gibbs EM; Clarke NF; Rose K; Oates EC; Webster R; Feldman EL; Dowling JJ
    J Mol Med (Berl); 2013 Jun; 91(6):727-37. PubMed ID: 23338057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype.
    Fajardo VA; Bombardier E; McMillan E; Tran K; Wadsworth BJ; Gamu D; Hopf A; Vigna C; Smith IC; Bellissimo C; Michel RN; Tarnopolsky MA; Quadrilatero J; Tupling AR
    Dis Model Mech; 2015 Aug; 8(8):999-1009. PubMed ID: 26035394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.